United States (US) Biotechnology 麻豆原创 Summary, Competitive Analysis and Forecast to 2028
Summary
Biotechnology in the United States industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications.
- The US biotechnology market recorded revenues of $361.6 billion in 2023, representing a compound annual growth rate (CAGR) of 12.7% between 2018 and 2023.
- The medical/healthcare segment accounted for the market's largest proportion in 2023, with total revenues of $236.2 billion, equivalent to 65.3% of the market's overall value.
- The US biotechnology market experienced a contraction in 2023 due to challenges and a record number of biotech bankruptcies. As reported until October 2023, 28 biotech firms have declared bankruptcy, a significant increase compared to previous years. Despite a global uptick in biotech funding reaching $75 billion, this represents only 50% of the peak during the pandemic.
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the United States
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in the United States
- Leading company profiles reveal details of key biotechnology market players鈥� global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the United States biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the United States biotechnology market by value in 2023?
- What will be the size of the United States biotechnology market in 2028?
- What factors are affecting the strength of competition in the United States biotechnology market?
- How has the market performed over the last five years?
- Who are the top competitors in the United States's biotechnology market?
Table of Contents
1 Executive Summary
1.1. 麻豆原创 value
1.2. 麻豆原创 value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. 麻豆原创 rivalry
1.6. Competitive landscape
2 麻豆原创 Overview
2.1. 麻豆原创 definition
2.2. 麻豆原创 analysis
3 麻豆原创 Data
3.1. 麻豆原创 value
4 麻豆原创 Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 麻豆原创 Outlook
5.1. 麻豆原创 value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do the leading players follow?
7.3. What is the rationale behind recent M&A activity?
8 Company Profiles
8.1. Johnson & Johnson
8.2. AbbVie Inc.
8.3. Amgen, Inc.
8.4. Biogen, Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related 麻豆原创Line research
10.4. About 麻豆原创Line
List of Tables
List of Tables
Table 1: United States biotechnology industry value: $ million, 2018-23
Table 2: United States biotechnology industry category segmentation: % share, by value, 2018-2023
Table 3: United States biotechnology industry category segmentation: $ million, 2018-2023
Table 4: United States biotechnology industry geography segmentation: $ million, 2023
Table 5: United States biotechnology industry value forecast: $ million, 2023-28
Table 6: Johnson & Johnson: key facts
Table 7: Johnson & Johnson: Annual Financial Ratios
Table 8: Johnson & Johnson: Key Employees
Table 9: Johnson & Johnson: Key Employees Continued
Table 10: AbbVie Inc.: key facts
Table 11: AbbVie Inc.: Annual Financial Ratios
Table 12: AbbVie Inc.: Key Employees
Table 13: AbbVie Inc.: Key Employees Continued
Table 14: Amgen, Inc.: key facts
Table 15: Amgen, Inc.: Annual Financial Ratios
Table 16: Amgen, Inc.: Key Employees
Table 17: Amgen, Inc.: Key Employees Continued
Table 18: Biogen, Inc.: key facts
Table 19: Biogen, Inc.: Annual Financial Ratios
Table 20: Biogen, Inc.: Key Employees
Table 21: Biogen, Inc.: Key Employees Continued
Table 22: United States size of population (million), 2019-23
Table 23: United States gdp (constant 2005 prices, $ billion), 2019-23
Table 24: United States gdp (current prices, $ billion), 2019-23
Table 25: United States inflation, 2019-23
Table 26: United States consumer price index (absolute), 2019-23
Table 27: United States exchange rate, 2019-23
List of Figures
List of Figures
Figure 1: United States biotechnology industry value: $ million, 2018-23
Figure 2: United States biotechnology industry category segmentation: $ million, 2018-2023
Figure 3: United States biotechnology industry geography segmentation: % share, by value, 2023
Figure 4: United States biotechnology industry value forecast: $ million, 2023-28
Figure 5: Forces driving competition in the biotechnology industry in the United States, 2023
Figure 6: Drivers of buyer power in the biotechnology industry in the United States, 2023
Figure 7: Drivers of supplier power in the biotechnology industry in the United States, 2023
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in the United States, 2023
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in the United States, 2023
Figure 10: Drivers of degree of rivalry in the biotechnology industry in the United States, 2023
Johnson & Johnson
AbbVie Inc.
Amgen, Inc.
Biogen, Inc.
听
听
*If Applicable.
